| Income Statement |
| Total Revenue | 22.15M |
|
| Revenues (USD) | 22.15M |
| Cost of Revenue | 6.29M |
| Gross Profit | 15.86M |
| Operating Expenses | 14.78M |
| Research and Development Expense | 7.29M |
| Selling, General and Administrative Expense | 7.49M |
| Operating Income | 1.08M |
| Income Tax Expense | 317.00K |
| Net Income | 1.30M |
| Net Income Common Stock | 1.30M |
| Net Income Common Stock (USD) | 1.30M |
| Consolidated Income | 1.30M |
| Earnings per Basic Share | 0.05 |
| Earnings per Basic Share (USD) | 0.05 |
| Earnings per Diluted Share | 0.05 |
| Earning Before Interest & Taxes (EBIT) | 1.62M |
| Earning Before Interest & Taxes (USD) | 1.62M |
| Weighted Average Shares | 27.07M |
| Weighted Average Shares Diluted | 27.58M |
| Balance Sheet |
| Cash and Equivalents | 73.34M |
| Cash and Equivalents (USD) | 73.34M |
| Trade and Non-Trade Receivables | 24.39M |
| Current Assets | 101.99M |
| Property, Plant & Equipment Net | 3.39M |
| Total Assets | 148.00M |
| Debt Current | 1.25M |
| Total Debt | 2.78M |
| Current Liabilities | 59.09M |
| Debt Non-Current | 1.53M |
| Total Liabilities | 63.78M |
| Accumulated Retained Earnings (Deficit) | -282.53M |
| Accumulated Other Comprehensive Income | -1.68M |
| Shareholders Equity | 84.21M |
| Shareholders Equity (USD) | 84.21M |
| Assets Non-Current | 46.00M |
| Total Debt (USD) | 2.78M |
| Deferred Revenue | 48.54M |
| Goodwill and Intangible Assets | 15.16M |
| Liabilities Non-Current | 4.70M |
| Trade and Non-Trade Payables | 2.49M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 405.00K |
| Net Cash Flow from Financing | -9.47M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.13M |
| Capital Expenditure | -95.00K |
| Issuance (Purchase) of Equity Shares | -9.47M |
| Net Cash Flow from Investing | -95.00K |
| Net Cash Flow from Operations | 2.42M |
| Effect of Exchange Rate Changes on Cash | 25.00K |
| Share Based Compensation | 845.00K |